Table 1 Baseline demographic and clinical characteristics of patients with high-apical and low-body plaques
From: Atherosclerotic plaque locations may be related to different ischemic lesion patterns
Variables | High-apical type (n = 31) | Low-body type (n = 62) | P value |
|---|---|---|---|
Age, y | 72.7 ± 6.8 | 71.7 ± 9.0 | 0.588 |
Male sex | 23 (74.2) | 52 (83.9) | 0.265 |
Hypertension | 25 (80.6) | 48 (77.4) | 0.721 |
Diabetes mellitus | 12 (38.7) | 21 (33.9) | 0.646 |
Hyperlipidemia | 15 (48.4) | 45 (72.6) | 0.022 |
Smoking | 17 (54.8) | 36 (58.1) | 0.767 |
History of stroke or TIA | 11 (35.5) | 15 (24.2) | 0.253 |
Previous medication | |||
Antiplatelet | 12 (38.7) | 30 (48.4) | 0.377 |
Statin | 9 (29.0) | 25 (40.3) | 0.287 |
Laboratory findings | |||
WBC, per mm2 | 9144.2 ± 5383.2 | 8514.7 ± 2669.0 | 0.452 |
Hematocrit | 38.8 ± 6.2 | 40.6 ± 4.9 | 0.119 |
Platelet, × 103/mm2 | 264.0 ± 115.2 | 236.8 ± 65.8 | 0.152 |
Glucose, mg/dL | 124.9 ± 36.8 | 137.3 ± 53.6 | 0.262 |
Glycated hemoglobin (HbA1c) | 6.3 ± 1.1 | 6.5 ± 1.4 | 0.610 |
Total cholesterol, mg/dL | 159.5 ± 55.9 | 170.7 ± 51.4 | 0.341 |
HDL cholesterol, mg/dL | 37.7 ± 8.8 | 40.7 ± 11.4 | 0.202 |
Triglyceride, mg/dL | 132.6 ± 80.1 | 146.3 ± 104.4 | 0.523 |
LDL cholesterol, mg/dL | 106.4 ± 41.7 | 108.8 ± 39.9 | 0.785 |
BUN, mg/dL | 17.0 ± 6.0 | 18.6 ± 7.4 | 0.303 |
Creatinine, mg/dL | 0.9 ± 0.3 | 1.0 ± 0.7 | 0.679 |
CRP, mg/dL | 1.2 ± 3.9 | 0.7 ± 2.1 | 0.393 |